 | • レポートコード：MR2211MG12825 • 出版社/出版日：Market Monitor Global / 2022年11月 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：製薬・ヘルスケア |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥625,300 (USD4,225) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、動物用生物学的ワクチンのグローバル市場規模と予測を記載しています。・動物用生物学的ワクチンのグローバル市場：売上、2017年-2022年、2023年-2028年 ・動物用生物学的ワクチンのグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 動物用生物学的ワクチンのグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「弱毒生ワクチン」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 動物用生物学的ワクチンのグローバル主要企業は、Merck、 Zoetis、 Boehringer Ingelheim、 Ceva、 CAHIC、 HVRI、 Yebio、 DHN、 WINSUN、 Elanco、 Virbac、 CAVAC、 Kyoto Biken Laboratories、 FATRO、 Vaksindo、 Bio-Labs、 Avimex Animal Health、 MEVAC、 Biovac、 Atafen、 Dyntec、 Ringpu Biology、 Jinyu Bio-technology、 Jinhe Biotechnology、 China Animal Husbandry Industry、 Wなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、動物用生物学的ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の動物用生物学的ワクチン市場：タイプ別、2017年-2022年、2023年-2028年 世界の動物用生物学的ワクチン市場：タイプ別市場シェア、2021年 ・弱毒生ワクチン、不活化ワクチン、その他 世界の動物用生物学的ワクチン市場：用途別、2017年-2022年、2023年-2028年 世界の動物用生物学的ワクチン市場：用途別市場シェア、2021年 ・畜産、豚、鶏、その他 世界の動物用生物学的ワクチン市場：地域・国別、2017年-2022年、2023年-2028年 世界の動物用生物学的ワクチン市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における動物用生物学的ワクチンのグローバル売上、2017年-2022年 ・主要企業における動物用生物学的ワクチンのグローバル売上シェア、2021年 ・主要企業における動物用生物学的ワクチンのグローバル販売量、2017年-2022年 ・主要企業における動物用生物学的ワクチンのグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 Merck、 Zoetis、 Boehringer Ingelheim、 Ceva、 CAHIC、 HVRI、 Yebio、 DHN、 WINSUN、 Elanco、 Virbac、 CAVAC、 Kyoto Biken Laboratories、 FATRO、 Vaksindo、 Bio-Labs、 Avimex Animal Health、 MEVAC、 Biovac、 Atafen、 Dyntec、 Ringpu Biology、 Jinyu Bio-technology、 Jinhe Biotechnology、 China Animal Husbandry Industry、 W ************************************************************* ・調査・分析レポートの概要 動物用生物学的ワクチン市場の定義 市場セグメント 世界の動物用生物学的ワクチン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の動物用生物学的ワクチン市場規模 世界の動物用生物学的ワクチン市場規模：2021年 VS 2028年 世界の動物用生物学的ワクチン市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの動物用生物学的ワクチンの売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業の動物用生物学的ワクチン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：弱毒生ワクチン、不活化ワクチン、その他 動物用生物学的ワクチンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：畜産、豚、鶏、その他 動物用生物学的ワクチンの用途別グローバル売上・予測 ・地域別市場分析 地域別動物用生物学的ワクチン市場規模 2021年と2028年 地域別動物用生物学的ワクチン売上・予測 北米市場 - アメリカの動物用生物学的ワクチン市場規模2017年-2028年 - カナダの動物用生物学的ワクチン市場規模2017年-2028年 - メキシコの動物用生物学的ワクチン市場規模2017年-2028年 ヨーロッパ市場 - ドイツの動物用生物学的ワクチン市場規模2017年-2028年 - フランスの動物用生物学的ワクチン市場規模2017年-2028年 - イギリスの動物用生物学的ワクチン市場規模2017年-2028年 - イタリアの動物用生物学的ワクチン市場規模2017年-2028年 - ロシアの動物用生物学的ワクチン市場規模2017年-2028年 アジア市場 - 中国の動物用生物学的ワクチン市場規模2017年-2028年 - 日本の動物用生物学的ワクチン市場規模2017年-2028年 - 韓国の動物用生物学的ワクチン市場規模2017年-2028年 - 東南アジアの動物用生物学的ワクチン市場規模2017年-2028年 - インドの動物用生物学的ワクチン市場規模2017年-2028年 南米市場 - ブラジルの動物用生物学的ワクチン市場規模2017年-2028年 - アルゼンチンの動物用生物学的ワクチン市場規模2017年-2028年 中東・アフリカ市場 - トルコの動物用生物学的ワクチン市場規模2017年-2028年 - イスラエルの動物用生物学的ワクチン市場規模2017年-2028年 - サウジアラビアの動物用生物学的ワクチン市場規模2017年-2028年 - UAEの動物用生物学的ワクチン市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Merck、 Zoetis、 Boehringer Ingelheim、 Ceva、 CAHIC、 HVRI、 Yebio、 DHN、 WINSUN、 Elanco、 Virbac、 CAVAC、 Kyoto Biken Laboratories、 FATRO、 Vaksindo、 Bio-Labs、 Avimex Animal Health、 MEVAC、 Biovac、 Atafen、 Dyntec、 Ringpu Biology、 Jinyu Bio-technology、 Jinhe Biotechnology、 China Animal Husbandry Industry、 W ... |
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
This report contains market size and forecasts of Veterinary Biological Vaccines in global, including the following market information:
Global Veterinary Biological Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Veterinary Biological Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Veterinary Biological Vaccines companies in 2021 (%)
The global Veterinary Biological Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Live Attenuated Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Veterinary Biological Vaccines include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Yebio, DHN and WINSUN, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Veterinary Biological Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Biological Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Veterinary Biological Vaccines Market Segment Percentages, by Type, 2021 (%)
Live Attenuated Vaccines
Inactivated Vaccines
Others
Global Veterinary Biological Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Veterinary Biological Vaccines Market Segment Percentages, by Application, 2021 (%)
Livestock
Swine
Chicken
Others
Global Veterinary Biological Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Veterinary Biological Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Veterinary Biological Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Veterinary Biological Vaccines revenues share in global market, 2021 (%)
Key companies Veterinary Biological Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Veterinary Biological Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Yebio
DHN
WINSUN
Elanco
Virbac
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
Ringpu Biology
Jinyu Bio-technology
Jinhe Biotechnology
China Animal Husbandry Industry
Wuhan Keqian Biology
Pulike Biological Engineering
Chengdu Kanghua Biological Products
1 Introduction to Research & Analysis Reports
1.1 Veterinary Biological Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Veterinary Biological Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Veterinary Biological Vaccines Overall Market Size
2.1 Global Veterinary Biological Vaccines Market Size: 2021 VS 2028
2.2 Global Veterinary Biological Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Veterinary Biological Vaccines Sales: 2017-2028
3 Company Landscape
3.1 Top Veterinary Biological Vaccines Players in Global Market
3.2 Top Global Veterinary Biological Vaccines Companies Ranked by Revenue
3.3 Global Veterinary Biological Vaccines Revenue by Companies
3.4 Global Veterinary Biological Vaccines Sales by Companies
3.5 Global Veterinary Biological Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Veterinary Biological Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Veterinary Biological Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Veterinary Biological Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Veterinary Biological Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Veterinary Biological Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Veterinary Biological Vaccines Market Size Markets, 2021 & 2028
4.1.2 Live Attenuated Vaccines
4.1.3 Inactivated Vaccines
4.1.4 Others
4.2 By Type – Global Veterinary Biological Vaccines Revenue & Forecasts
4.2.1 By Type – Global Veterinary Biological Vaccines Revenue, 2017-2022
4.2.2 By Type – Global Veterinary Biological Vaccines Revenue, 2023-2028
4.2.3 By Type – Global Veterinary Biological Vaccines Revenue Market Share, 2017-2028
4.3 By Type – Global Veterinary Biological Vaccines Sales & Forecasts
4.3.1 By Type – Global Veterinary Biological Vaccines Sales, 2017-2022
4.3.2 By Type – Global Veterinary Biological Vaccines Sales, 2023-2028
4.3.3 By Type – Global Veterinary Biological Vaccines Sales Market Share, 2017-2028
4.4 By Type – Global Veterinary Biological Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application – Global Veterinary Biological Vaccines Market Size, 2021 & 2028
5.1.2 Livestock
5.1.3 Swine
5.1.4 Chicken
5.1.5 Others
5.2 By Application – Global Veterinary Biological Vaccines Revenue & Forecasts
5.2.1 By Application – Global Veterinary Biological Vaccines Revenue, 2017-2022
5.2.2 By Application – Global Veterinary Biological Vaccines Revenue, 2023-2028
5.2.3 By Application – Global Veterinary Biological Vaccines Revenue Market Share, 2017-2028
5.3 By Application – Global Veterinary Biological Vaccines Sales & Forecasts
5.3.1 By Application – Global Veterinary Biological Vaccines Sales, 2017-2022
5.3.2 By Application – Global Veterinary Biological Vaccines Sales, 2023-2028
5.3.3 By Application – Global Veterinary Biological Vaccines Sales Market Share, 2017-2028
5.4 By Application – Global Veterinary Biological Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region – Global Veterinary Biological Vaccines Market Size, 2021 & 2028
6.2 By Region – Global Veterinary Biological Vaccines Revenue & Forecasts
6.2.1 By Region – Global Veterinary Biological Vaccines Revenue, 2017-2022
6.2.2 By Region – Global Veterinary Biological Vaccines Revenue, 2023-2028
6.2.3 By Region – Global Veterinary Biological Vaccines Revenue Market Share, 2017-2028
6.3 By Region – Global Veterinary Biological Vaccines Sales & Forecasts
6.3.1 By Region – Global Veterinary Biological Vaccines Sales, 2017-2022
6.3.2 By Region – Global Veterinary Biological Vaccines Sales, 2023-2028
6.3.3 By Region – Global Veterinary Biological Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country – North America Veterinary Biological Vaccines Revenue, 2017-2028
6.4.2 By Country – North America Veterinary Biological Vaccines Sales, 2017-2028
6.4.3 US Veterinary Biological Vaccines Market Size, 2017-2028
6.4.4 Canada Veterinary Biological Vaccines Market Size, 2017-2028
6.4.5 Mexico Veterinary Biological Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country – Europe Veterinary Biological Vaccines Revenue, 2017-2028
6.5.2 By Country – Europe Veterinary Biological Vaccines Sales, 2017-2028
6.5.3 Germany Veterinary Biological Vaccines Market Size, 2017-2028
6.5.4 France Veterinary Biological Vaccines Market Size, 2017-2028
6.5.5 U.K. Veterinary Biological Vaccines Market Size, 2017-2028
6.5.6 Italy Veterinary Biological Vaccines Market Size, 2017-2028
6.5.7 Russia Veterinary Biological Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries Veterinary Biological Vaccines Market Size, 2017-2028
6.5.9 Benelux Veterinary Biological Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region – Asia Veterinary Biological Vaccines Revenue, 2017-2028
6.6.2 By Region – Asia Veterinary Biological Vaccines Sales, 2017-2028
6.6.3 China Veterinary Biological Vaccines Market Size, 2017-2028
6.6.4 Japan Veterinary Biological Vaccines Market Size, 2017-2028
6.6.5 South Korea Veterinary Biological Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia Veterinary Biological Vaccines Market Size, 2017-2028
6.6.7 India Veterinary Biological Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country – South America Veterinary Biological Vaccines Revenue, 2017-2028
6.7.2 By Country – South America Veterinary Biological Vaccines Sales, 2017-2028
6.7.3 Brazil Veterinary Biological Vaccines Market Size, 2017-2028
6.7.4 Argentina Veterinary Biological Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Veterinary Biological Vaccines Revenue, 2017-2028
6.8.2 By Country – Middle East & Africa Veterinary Biological Vaccines Sales, 2017-2028
6.8.3 Turkey Veterinary Biological Vaccines Market Size, 2017-2028
6.8.4 Israel Veterinary Biological Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia Veterinary Biological Vaccines Market Size, 2017-2028
6.8.6 UAE Veterinary Biological Vaccines Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Veterinary Biological Vaccines Major Product Offerings
7.1.4 Merck Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 Merck Key News
7.2 Zoetis
7.2.1 Zoetis Corporate Summary
7.2.2 Zoetis Business Overview
7.2.3 Zoetis Veterinary Biological Vaccines Major Product Offerings
7.2.4 Zoetis Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 Zoetis Key News
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporate Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Veterinary Biological Vaccines Major Product Offerings
7.3.4 Boehringer Ingelheim Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 Boehringer Ingelheim Key News
7.4 Ceva
7.4.1 Ceva Corporate Summary
7.4.2 Ceva Business Overview
7.4.3 Ceva Veterinary Biological Vaccines Major Product Offerings
7.4.4 Ceva Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 Ceva Key News
7.5 CAHIC
7.5.1 CAHIC Corporate Summary
7.5.2 CAHIC Business Overview
7.5.3 CAHIC Veterinary Biological Vaccines Major Product Offerings
7.5.4 CAHIC Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 CAHIC Key News
7.6 HVRI
7.6.1 HVRI Corporate Summary
7.6.2 HVRI Business Overview
7.6.3 HVRI Veterinary Biological Vaccines Major Product Offerings
7.6.4 HVRI Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 HVRI Key News
7.7 Yebio
7.7.1 Yebio Corporate Summary
7.7.2 Yebio Business Overview
7.7.3 Yebio Veterinary Biological Vaccines Major Product Offerings
7.7.4 Yebio Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 Yebio Key News
7.8 DHN
7.8.1 DHN Corporate Summary
7.8.2 DHN Business Overview
7.8.3 DHN Veterinary Biological Vaccines Major Product Offerings
7.8.4 DHN Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 DHN Key News
7.9 WINSUN
7.9.1 WINSUN Corporate Summary
7.9.2 WINSUN Business Overview
7.9.3 WINSUN Veterinary Biological Vaccines Major Product Offerings
7.9.4 WINSUN Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 WINSUN Key News
7.10 Elanco
7.10.1 Elanco Corporate Summary
7.10.2 Elanco Business Overview
7.10.3 Elanco Veterinary Biological Vaccines Major Product Offerings
7.10.4 Elanco Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.10.5 Elanco Key News
7.11 Virbac
7.11.1 Virbac Corporate Summary
7.11.2 Virbac Veterinary Biological Vaccines Business Overview
7.11.3 Virbac Veterinary Biological Vaccines Major Product Offerings
7.11.4 Virbac Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.11.5 Virbac Key News
7.12 CAVAC
7.12.1 CAVAC Corporate Summary
7.12.2 CAVAC Veterinary Biological Vaccines Business Overview
7.12.3 CAVAC Veterinary Biological Vaccines Major Product Offerings
7.12.4 CAVAC Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.12.5 CAVAC Key News
7.13 Kyoto Biken Laboratories
7.13.1 Kyoto Biken Laboratories Corporate Summary
7.13.2 Kyoto Biken Laboratories Veterinary Biological Vaccines Business Overview
7.13.3 Kyoto Biken Laboratories Veterinary Biological Vaccines Major Product Offerings
7.13.4 Kyoto Biken Laboratories Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.13.5 Kyoto Biken Laboratories Key News
7.14 FATRO
7.14.1 FATRO Corporate Summary
7.14.2 FATRO Business Overview
7.14.3 FATRO Veterinary Biological Vaccines Major Product Offerings
7.14.4 FATRO Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.14.5 FATRO Key News
7.15 Vaksindo
7.15.1 Vaksindo Corporate Summary
7.15.2 Vaksindo Business Overview
7.15.3 Vaksindo Veterinary Biological Vaccines Major Product Offerings
7.15.4 Vaksindo Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.15.5 Vaksindo Key News
7.16 Bio-Labs
7.16.1 Bio-Labs Corporate Summary
7.16.2 Bio-Labs Business Overview
7.16.3 Bio-Labs Veterinary Biological Vaccines Major Product Offerings
7.16.4 Bio-Labs Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.16.5 Bio-Labs Key News
7.17 Avimex Animal Health
7.17.1 Avimex Animal Health Corporate Summary
7.17.2 Avimex Animal Health Business Overview
7.17.3 Avimex Animal Health Veterinary Biological Vaccines Major Product Offerings
7.17.4 Avimex Animal Health Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.17.5 Avimex Animal Health Key News
7.18 MEVAC
7.18.1 MEVAC Corporate Summary
7.18.2 MEVAC Business Overview
7.18.3 MEVAC Veterinary Biological Vaccines Major Product Offerings
7.18.4 MEVAC Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.18.5 MEVAC Key News
7.19 Biovac
7.19.1 Biovac Corporate Summary
7.19.2 Biovac Business Overview
7.19.3 Biovac Veterinary Biological Vaccines Major Product Offerings
7.19.4 Biovac Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.19.5 Biovac Key News
7.20 Atafen
7.20.1 Atafen Corporate Summary
7.20.2 Atafen Business Overview
7.20.3 Atafen Veterinary Biological Vaccines Major Product Offerings
7.20.4 Atafen Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.20.5 Atafen Key News
7.21 Dyntec
7.21.1 Dyntec Corporate Summary
7.21.2 Dyntec Business Overview
7.21.3 Dyntec Veterinary Biological Vaccines Major Product Offerings
7.21.4 Dyntec Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.21.5 Dyntec Key News
7.22 Ringpu Biology
7.22.1 Ringpu Biology Corporate Summary
7.22.2 Ringpu Biology Business Overview
7.22.3 Ringpu Biology Veterinary Biological Vaccines Major Product Offerings
7.22.4 Ringpu Biology Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.22.5 Ringpu Biology Key News
7.23 Jinyu Bio-technology
7.23.1 Jinyu Bio-technology Corporate Summary
7.23.2 Jinyu Bio-technology Business Overview
7.23.3 Jinyu Bio-technology Veterinary Biological Vaccines Major Product Offerings
7.23.4 Jinyu Bio-technology Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.23.5 Jinyu Bio-technology Key News
7.24 Jinhe Biotechnology
7.24.1 Jinhe Biotechnology Corporate Summary
7.24.2 Jinhe Biotechnology Business Overview
7.24.3 Jinhe Biotechnology Veterinary Biological Vaccines Major Product Offerings
7.24.4 Jinhe Biotechnology Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.24.5 Jinhe Biotechnology Key News
7.25 China Animal Husbandry Industry
7.25.1 China Animal Husbandry Industry Corporate Summary
7.25.2 China Animal Husbandry Industry Business Overview
7.25.3 China Animal Husbandry Industry Veterinary Biological Vaccines Major Product Offerings
7.25.4 China Animal Husbandry Industry Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.25.5 China Animal Husbandry Industry Key News
7.26 Wuhan Keqian Biology
7.26.1 Wuhan Keqian Biology Corporate Summary
7.26.2 Wuhan Keqian Biology Business Overview
7.26.3 Wuhan Keqian Biology Veterinary Biological Vaccines Major Product Offerings
7.26.4 Wuhan Keqian Biology Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.26.5 Wuhan Keqian Biology Key News
7.27 Pulike Biological Engineering
7.27.1 Pulike Biological Engineering Corporate Summary
7.27.2 Pulike Biological Engineering Business Overview
7.27.3 Pulike Biological Engineering Veterinary Biological Vaccines Major Product Offerings
7.27.4 Pulike Biological Engineering Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.27.5 Pulike Biological Engineering Key News
7.28 Chengdu Kanghua Biological Products
7.28.1 Chengdu Kanghua Biological Products Corporate Summary
7.28.2 Chengdu Kanghua Biological Products Business Overview
7.28.3 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Major Product Offerings
7.28.4 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales and Revenue in Global (2017-2022)
7.28.5 Chengdu Kanghua Biological Products Key News
8 Global Veterinary Biological Vaccines Production Capacity, Analysis
8.1 Global Veterinary Biological Vaccines Production Capacity, 2017-2028
8.2 Veterinary Biological Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Veterinary Biological Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Veterinary Biological Vaccines Supply Chain Analysis
10.1 Veterinary Biological Vaccines Industry Value Chain
10.2 Veterinary Biological Vaccines Upstream Market
10.3 Veterinary Biological Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Veterinary Biological Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer